Chinese english Germany Japanese Korea

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE Struktur
65286-27-3
CAS-Nr.
65286-27-3
Englisch Name:
L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE
Synonyma:
Arg-MCA;ARG-MCA HYDROCHLORIDE;ARG-MCA(HYDROCHLORIDE FORM);arginine 4-methyl-7-coumarylamide;L-ARG-7-AMIDO-4-METHYLCOUMARIN HCL;L-ARGININE 4-METHYLCOUMARYL-7-AMIDE HYDROCHLORIDE;L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE;(2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide;Pentanamide, 2-amino-5-[(aminoiminomethyl)amino]-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (2S)-
CBNumber:
CB6135823
Summenformel:
C16H21N5O3
Molgewicht:
331.37
MOL-Datei:
65286-27-3.mol
Request For Quotation

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE Eigenschaften

storage temp. 
−20°C

Sicherheit

WGK Germany  3

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE Chemische Eigenschaften,Einsatz,Produktion Methoden

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Toyang Biotechnology Co., LTD 021-59555769 13524932310
 1405894150@qq.com China 8221 58

65286-27-3()Verwandte Suche:

Benzyl-(S)-[4-(amidinoamino)-1-[[(4-methyl-2-oxo-2H-1-benzopyran-7-yl)amino]carbonyl]butyl]carbamatmonohydrochlorid
  • L-ARGININE 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE
  • L-ARG-7-AMIDO-4-METHYLCOUMARIN HCL
  • L-ARGININE 4-METHYLCOUMARYL-7-AMIDE HYDROCHLORIDE
  • ARG-MCA HYDROCHLORIDE
  • ARG-MCA(HYDROCHLORIDE FORM)
  • arginine 4-methyl-7-coumarylamide
  • (2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide
  • Pentanamide, 2-amino-5-[(aminoiminomethyl)amino]-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (2S)-
  • Arg-MCA
  • 65286-27-3
Copyright 2019 © ChemicalBook. All rights reserved